Medindia
Medindia LOGIN REGISTER
Advertisement

/C O R R E C T I O N -- Peregrine Pharmaceuticals, Inc./

Saturday, September 8, 2007 General News
Advertisement
In the news release, Peregrine (Nasdaq: PPHM) Reports Data ShowingBavituximab's Potential to Shrink Prostate Tumors, issued earlier today byPeregrine Pharmaceuticals, Inc. over PR Newswire, the headline should read"Peregrine Researchers Report Data Showing Bavituximab's Potential to ShrinkHuman Prostate Tumors in Model of Relapsed Disease" rather than "PeregrineReports Data Showing Bavituximab's Potential to Shrink Prostate Tumors" asincorrectly transmitted by PR Newswire.

SOURCE Peregrine Pharmaceuticals, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close